Je was op zoek naar: fibrin (Engels - Maltees)

fibrin support.
appoġġ ta’ fibrin.

fibrin degradation products
prodotti ta’ degradazzjoni ta’ fibrin

fibrin d-dimer increased
antikorpi li ma jinnewtralizzawx Żieda fil-fibrin d-dimer

increased fibrin degradation products
Żieda fil-prodotti ta’ degradazzjoni ta’ fibrin

evicel is a fibrin sealant.
evicel huwa siġillant li fih il-fibrina.

68.7%, non-fibrin specific:
68. 7%, mhux speċifiċi għall- fibrin:

evarrest contains the components of fibrin sealant.
evarrest™ fih il-komponenti tas-siġillant ta’ fibrin.

the fibrin monomers aggregate and form a fibrin clot.
il - monomeri ta 'fibrina jaggregaw u jifformaw fibrina magħquda.

this plasminogenolysis occurs preferentially in the presence of fibrin.
din il-plażminoġenolożi sseħħ preferenzjalment fil-preżenza tal-fibrin.

maci will be secured in place using a fibrin sealant.
maci jinżamm fil- post permezz ta’ siġillant tal-fibrina.

tenecteplase is a recombinant fibrin-specific plasminogen activator.
tenecteplase hu attivatur rikombinanti ta’ plasminogen li hu speċifiku għal fibrin.

thrombin then converts fibrinogen into fibrin and a clot is formed.
trombin imbagħad jibdel fibrinoġen għal fibrin u hekk jifforma embolu.

thrombin then converts fibrinogen into fibrin and a clot can be formed.
it-trombina mbagħad tibdel il-fibrinoġen f’fibrin u jista’ jinħoloq embolu.

no interaction studies with any other type of fibrin glues were performed.
ma sarux studji dwar l-effett ta’ tipi oħra ta’ kolol tal-fibrin fuq l-effett terapewtiku tal-prodott.

the fibrin adhesion system initiates the last phase of physiological blood coagulation.
is- sistema ta 'adeżjoni li fiha l- fibrina tagħti bidu għall- aħħar fażi tal- koagulazzjoni fiżjoloġika tad- demm.

antibodies against components of fibrin sealant/haemostatic products may occur rarely.
antikorpi kontra l-komponenti ta’ siġillanti tal-fibrin /prodotti emostatiċi jistgħu jseħħu b’mod rari.

conversion of fibrinogen into fibrin occurs by the splitting of fibrinogen into fibrin monomers and fibrinopeptides.
il - konverżjoni ta 'fibrinoġen f' fibrina sseħħ bil- qsim ta' fibrinoġen f' monomeri ta 'fibrina u fibrinopeptidi.

as fibrin is lysed during reteplase therapy, bleeding from recent puncture sites may occur.
waqt li fibrin huwa ddiżintegrat waqt it-terapija b’reteplase, il-ħruġ tad-demm minn partijiet li kienu mtaqqba reċentement jista’ jseħħ.

when the two active substances are mixed together, thrombin cuts fibrinogen up into smaller units called fibrin.
meta ż-żewġ sustanzi attivi jitħalltu flimkien, it-trombina tqatta’ l-fibrinoġenu f’unitajiet iżgħar imsejħa fibrini.

dabigatran also inhibits free thrombin, fibrin-bound thrombin and thrombin-induced platelet aggregation.
dabigatran jinibixxi wkoll it- thrombin ħieles, it-thrombin imwaħħal mal-fibrin u l-aggregazzjoni tal-plejtlits ikkaġunata mit- thrombin.